Found: 68
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Pospekhova N.I., Shubin V.P., Tsukanov A.S., Kashnikov V.N., Frolov S.A., Achkasov S.I., Sushkov O.I., Shelygin Yu.A.
Introduction. Colorectal cancer (CRC) often metastasizes even if the tumor is small in size that is the main cause of death. Complex process of epithelial-mesenchymal transition (EMT) is required for dissemination of tumor cells. EMT leads to the transformatio…
Research article2014
Zenit-Zhuravleva E.G., Lushnikova A.A., Ponkratova D.A., Tsyganova I.V., Mikhailova I.N., Cheremushkin E.A., Vikhrova A.S., Treschalina E.M., Demidov L.V., Mazurenko N.N.
Introduction. The prevalence of human cutaneous melanoma (CM) in the world is constantly rising. Diagnostics and treatment of CM at the early stages allows to increase the 5-year patient survival up to 90%. This problem can be solved with personalized therapy …
Research article2014
Mazurenko N.N., Kushlinskii N.E.
Lung cancer is one of the most common oncologic diseases in the world and the most frequent cause of the death from malignant neoplasms. Last decade’s studies revealed significant number of molecular events leading to the onset and development of non-small cel…
Research article2013
Afanasyeva N.A., Khvostova E.P., Pustyl’nyak V.O., Chasovnikova O.B., Krasil’nikov S.E., Gulyaeva L.F.
Early diagnosis of ovarian cancer (OC) remains to be the actual problem in modern oncology due to the high mortality rate, asymptomatic course of the disease in the early stages and its aggressiveness. The aim was to study the genetic polymorphism of pathogene…
Research article2013
Stefanova L.B., Scherbakov A.M., Sorokin D.V., Shatskaya V.A., Krasilnikov M.A.
The main goal of the project was to study the heightened tolerance of the resistant breast cancer cells to hypoxia. Two in vitro cultured breast cancer cell lines, the estrogen-dependent MCF-7 cells and the resistant ER-negative HBL-100 cells were used in the …
Research article2013
Mazurenko N.N., Tsyganova I.V., Gagarin I.M., Chuev I.V., Mochalnikova V.V., Kolomeytseva A.A., Gorbunova V.A.
Last successful results in target therapy of cancer were achieved with different tyrosine kinases inhibitors (TKI). Target therapy of non-small cell lung cancer (NSCLC) with EGFR inhibitors gefitinib and erlotinib is effective only in patients with somatic mut…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ
Palkina N.V., Zemtsov D.S., Narkevich A.N., Bardetskaya Ya.V., Kirichenko A.K., Ruksha T.G.
Pre-metastatic niche formation precedes tumor dissemination although the mechanisms of it remain unclear. Therefore, the aim of the study was to evaluate the expression of molecules characterizing the microenvironment remodeling in target organs lungs and live…
ОБЗОР
Sergeeva E.Y., Fefelova Y.A., Bardezkaya Y.V.
Personalized therapy allows to reveal subtypes of diseases with similar symptoms but various molecular mechanisms of development. Different -omics (genomics, epigenomics, transcriptomics, proteomics ets) are used to divide the diseases into subtypes. Transcrip…